- Latest week
- 10 Jul 2026
- Close
- 257.899994
- Fair value
- 278.914754
- Next-week expectancy
- Positive 56.76%
GE9 Chart Pack
GENMAB AS N
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, GE9 rose 12.47%, moving from 229.30 to 257.90. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -24.92 and has remained broadly mixed across the 12-week window. Market Dynamics is 0.30 on the latest week. Next-week expectancy is positive at 56.76% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 257.90
- 12-Week Change
- 12.47%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Positive 56.76%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Below
- Relative Strength
- -24.92
- Market Dynamics
- 0.30
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 257.90
- 12-Week Change
- 12.47%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Positive 56.76%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Below
- Relative Strength
- -24.92
- Market Dynamics
- 0.30
Over the latest 12 completed weeks ending 2026-07-10, GE9 rose 12.47%, moving from 229.30 to 257.90. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -24.92 and has remained broadly mixed across the 12-week window. Market Dynamics is 0.30 on the latest week. Next-week expectancy is positive at 56.76% based on similar historical setup states.
Industry Peers
Germany equities in Biotechnology
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| HPHA Heidelberg Pharma AG | GER | 10 Jul 2026 | 2.56 | 2.79 | 2.56 | 2.66 | 3.91% |
| B72 AtaiBeckley Inc. | GER | 10 Jul 2026 | 4.46 | 4.72 | 4.24 | 4.60 | 3.14% |
| RGO Regeneron Pharmaceuticals, Inc. | GER | 10 Jul 2026 | 574.00 | 587.60 | 563.50 | 579.30 | 0.92% |
| BBZA BB Biotech AG | GER | 10 Jul 2026 | 33.40 | 33.40 | 33.40 | 33.40 | 0.00% |
| PSH0 Sernova Biotherapeutics Inc | GER | 10 Jul 2026 | 0.08 | 0.09 | 0.08 | 0.08 | 0.00% |
| FYB Formycon AG | GER | 10 Jul 2026 | 19.30 | 19.58 | 18.24 | 18.80 | -2.59% |
| NP5 Newron Pharmaceuticals S.p.A. | GER | 10 Jul 2026 | 13.40 | 13.50 | 12.80 | 13.05 | -2.61% |
| PTP Pentixapharm Holding AG N | GER | 10 Jul 2026 | 2.28 | 2.32 | 2.00 | 2.18 | -4.39% |
| AYJ Valneva SE | GER | 10 Jul 2026 | 2.32 | 2.35 | 2.19 | 2.19 | -5.39% |
| VX1 Vertex Pharmaceuticals Incorporated | GER | 10 Jul 2026 | 463.40 | 464.00 | 424.15 | 425.60 | -8.16% |